Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 529Neoplasms 475Carcinoma, Non-Small-Cell Lung 394Prostatic Neoplasms 308Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 218Ovarian Neoplasms 200Leukemia, Myeloid, Acute 199Pancreatic Neoplasms 187Multiple Myeloma 175Squamous Cell Carcinoma of Head and Neck 134Recurrence 132Stomach Neoplasms 131Brain Neoplasms 126Carcinoma, Hepatocellular 125Melanoma 124Endometrial Neoplasms 122Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 100Head and Neck Neoplasms 99Lymphoma 97Carcinoma, Renal Cell 97Urinary Bladder Neoplasms 93Sarcoma 90Glioma 88Lymphoma, Non-Hodgkin 82Rectal Neoplasms 81

Interventions

sodium thiosulfate 1Oxaliplatin 1Mitomycin 1Levetiracetam 1Fluorouracil 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Necrosis × 90 days × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT07130786 2026-03-19

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Brigham and Women's Hospital

Phase 2 Recruiting
150 enrolled
CNS

Brain Neoplasms, Necrosis, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡